- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips satisfied with medical results
Dutch conglomerate Philips Electronics last month reported that1996 sales in its Philips Medical Systems unit progressed welland that the company was satisfied with the division's operatingincome. Philips declined to break out specific sales and
Dutch conglomerate Philips Electronics last month reported that1996 sales in its Philips Medical Systems unit progressed welland that the company was satisfied with the division's operatingincome. Philips declined to break out specific sales and profitfigures for the unit, which is part of Philips' Professional Productsand Systems business.
As a whole, however, Philips reported disappointing financialresults for 1996, due to losses in its Grundig division and restructuringcharges. For the year, Philips Electronics posted revenues of$36.82 billion (69.2 billion Dutch guilders), up 7% compared with$34.3 billion in sales in 1995. The company had a net loss for1996 of $313.4 million, compared with net income in 1995 of $1.34billion.
Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging
January 20th 2025In an update of previous guidelines from the European Society of Urogenital Radiology published in 2010, a 21-expert panel offered consensus recommendations on the utility of CT, MRI and PET-CT in the staging and follow-up imaging for patients with ovarian cancer.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
